BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
...lts to differ materially from those contained in the projections or forward-looking statements. Contact: BioCryst Pharmaceuticals, Inc. Jonathan M. nugent V.P. Corporate Communications (205) 444-4633 ...BioCryst Updates Peramivir Clinical Development Plan
... to differ materially from those contained in the projections or forward-looking statements. Contact: BioCryst Pharmaceuticals, Inc. Jonathan M. nugent V.P. Corporate Communications (205) 444-4633 ...Ventus Medical Appoints John McCutcheon as President and CEO
...appointment of John McCutcheon as President and Chief Executive Officer, effective April 20, 2009. The company also announced that current CEO Jeffrey nugent will become Executive Chairman. (Logo: http://www.newscom.com/cgi-bin/prnh/20090409/SF96872LOGO ) Mr. McCutcheon joins Ventus Medical from...BioCryst to Present at UBS 2007 Global Life Sciences Conference
...lts to differ materially from those contained in the projections or forward-looking statements. Contact: BioCryst Pharmaceuticals, Inc. Jonathan M. nugent V.P. Corporate Communications (205) 444-4633 ...BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
...lts to differ materially from those contained in the projections or forward-looking statements. Contact: BioCryst Pharmaceuticals, Inc. Jonathan M. nugent V.P. Corporate Communications (205) 444-4633 ...